Diagnosing Breast Lesions with Contrast-Enhanced 3-Dimensional Power Doppler Imaging

Journal of Ultrasound in Medicine

Volumn 23, Issue 2, 2004, Pages 173-182

  Forsberg, Flemming ^a   Goldberg, Barry B ^a   Merritt, Christopher R B ^a   Parker, Laurence ^a   Maitino, Andrea J ^a   Palazzo, Juan J ^a   Merton, Daniel A ^a   Schultz, Susan M ^a   Needleman, Laurence ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

3 dimensional sonographic imaging; Breast cancer; Mammography; Sonographic contrast media

Indexed keywords

BIOLOGICAL ORGANS; BIOPSY; DOPPLER EFFECT; HISTOLOGY; IMAGING SYSTEMS; PATHOLOGY; SONOLUMINESCENCE; TUMORS; ULTRASONIC IMAGING;

HISTOPATHOLOGY; SONOGRAPHY;

MAMMOGRAPHY;

FS 069; SHU 508;

ADULT; ANASTOMOSIS; AREA UNDER THE CURVE; ARTICLE; BENIGN TUMOR; BREAST CANCER; CALCULATION; CANCER CYTODIAGNOSIS; CANCER PATIENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DOPPLER FLOWMETRY; ECHOMAMMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALIGNANT NEOPLASTIC DISEASE; MAMMOGRAPHY; RANK SUM TEST; RECEIVER OPERATING CHARACTERISTIC; THREE DIMENSIONAL IMAGING; TUMOR VASCULARIZATION;

EID: 1042301352     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2004.23.2.173     Document Type: Article

References (35)

1. Feig SA. Breast masses: mammographic and sonographic evaluation. Radiol Clin North Am 1992; 30:67-92.
2. Kopans DB. Breast Imaging. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1998.
3. Jackson V. The role of US in breast imaging. Radiology 1990; 177:305-311.
4. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995; 196:123-134.
5. Taylor KJW, Merritt C, Piccoli C, et al. Ultrasound as a complement to mammography and breast examination to characterize breast masses. Ultrasound Med Biol 2002; 28:19-26.
6. Bohm-Velez M, Mendelson EB. Computed tomography, duplex Doppler ultrasound and magnetic resonance imaging in evaluating the breast. Semin Ultrasound CT MR 1989; 10:171-176.
7. Adler DD, Carson PL, Rubin JM, Quinn-Reid D. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings. Ultrasound Med Biol 1990; 16:553-559.
8. Ferrara KF, Merritt CRB, Burns PN, Foster S, Mattrey RF, Wickline SA. Evaluation of tumor angiogenesis with US: imaging, Doppler and contrast agents. Acad Radiol 2000; 7:824-839.
9. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast cancer. J Natl Cancer Inst 1992; 84:1875-1887.
10. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995; 13:765-782.
11. Relf M, LeJeune S, Scott PA, et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997; 57:963-969.
12. Goldberg BB, Merton DA, Forsberg F, Liu JB, Rawool NM. Color amplitude imaging: preliminary results using vascular sonographic contrast. J Ultrasound Med 1996; 15:127-134.
13. Forsberg F, Merton DA, Liu JB, Needleman L, Goldberg BB. Clinical applications of ultrasound contrast agents. Ultrasonics 1998; 36:695-701.
14. Goldberg BB, Raichlen JS, Forsberg F. Ultrasound Contrast Agents: Basic Principles and Clinical Applications. 2nd ed. London, England: Martin Dunitz Ltd; 2001.
15. Nelson TR, Pretorius DH. Three-dimensional ultrasound imaging. Ultrasound Med Biol 1998; 24:1243-1270.
16. Fenster A, Downey DB. Three-dimensional ultrasound imaging. Annu Rev Biomed Eng 2000; 2:457-475.
17. Forsberg F, Rawool NM, Merton DA, Liu JB, Goldberg BB. Contrast enhanced vascular 3D ultrasound imaging. Ultrasonics 2002; 40:117-122.
18. Forsberg F, Liu JB, Burns PN, Merton DA, Goldberg BB. Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 1994; 13:357-365.
19. Seidel G, Vidal-Langwasser M, Algermissen C, Gerriets T, Kaps M. The influence of Doppler system settings on the clearance kinetics of different ultrasound contrast agents. Eur J Ultrasound 1999; 9:167-175.
20. Correas JM, Meuter AR, Singlas E, Kessler DR, Worah D, Quay SC. Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography. Ultrasound Med Biol 2001; 27:565-570.
21. Rosner B. Fundamentals of Biostatistics. 3rd ed. Boston, MA: PWS-Kent Publishing Co; 1990.
22. Metz CE. ROC methodology in radiologic imaging. Invest Radiol 1986; 21:720-733.
23. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845.
24. Goldberg BB, Merritt CRB, Needleman L, et al. Contrast-enhanced ultrasound and mammography for breast cancer detection [abstract]. J Ultrasound Med 2001; 20(suppl):S95.
25. Albrecht T, Hoffman CW, Schettler S, et al. B-mode enhancement using phase-inversion US with air-based microbubble contrast agent: initial experience in humans. Radiology 2000; 216:273-278.
26. Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma and metastasis. Radiology 2000; 215:153-161.
27. Kim TK, Choi BI, Han JK, Park SH, Moon SG. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000; 216:411-417.
28. Furuse F, Forsberg F, Goldberg BB, et al. Pulse inversion harmonic imaging for breast cancer diagnosis [abstract]. Ultrasound Med Biol 2003 (suppl); 29:S93-S94.
29. Kedar RP, Cosgrove D, McCready VR, Bamber JC, Carter ER. Microbubbble contrast agent for color Doppler US: effect on breast masses. Radiology 1996; 198:679-686.
30. Madjar H, Prompeler HJ, Del Favero C, Hackeloer BJ, Llull JB. A new Doppler signal enhancing agent for flow assessment in breast lesions. Eur J Ultrasound 2000; 12:123-130.
31. Stuhrmann M, Aronius R, Schietzel M. Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography. AJR Am J Roentgenol 2000; 175:1585-1589.
32. Kim SW, Park SS, Ahn SJ, et al. Identification of angiogenesis in primary breast carcinoma according to the image analysis. Breast Cancer Res Treat 2002; 74:121-129.
33. Yang WT, Tse GMK, Lam PKW, Metreweli C, Chang J. Correlation between color power Doppler sonographic measurement of tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis. J Ultrasound Med 2002; 21:1227-1235.
34. Hochmuth A, Boehm T, Bitzer C, Fleck M, Schneider A, Kaiser WA. Differentiation of breast masses using 3-D sonographic and echo-enhancer-based evaluation of the vascular pattern: initial experiences. Ultrasound Med Biol 2002; 28:845-851.
35. Chaudhari MH, Forsberg F, Voodarla A, et al. Breast tumor vascularity identified by contrast enhanced ultrasound and pathology: initial results. Ultrasonics 2000; 38:105-109.